Wookey Alice F, Chollangi Tejasvy, Yong Hannah E J, Kalionis Bill, Brennecke Shaun P, Murthi Padma, Georgiou Harry M
Department of Maternal-Fetal Medicine, Pregnancy Research Centre, Royal Women's Hospital, Parkville, VIC 3052, Australia.
Department of Maternal-Fetal Medicine, Pregnancy Research Centre, Royal Women's Hospital, Parkville, VIC 3052, Australia; Department of Obstetrics and Gynaecology, University of Melbourne, Royal Women's Hospital, Parkville, VIC 3052, Australia.
J Pregnancy. 2017;2017:5120267. doi: 10.1155/2017/5120267. Epub 2017 Feb 15.
Vitamin D-binding protein is a multifunctional serum protein with multiple actions related to normal health. Vitamin D-binding protein transports vitamin D and influences the metabolism of this key hormone but it also has additional immunomodulatory and actin-clearing properties. We investigated whether vitamin D-binding protein expression is altered in fetal growth restriction-associated placental dysfunction. Protein was extracted from 35 placentae derived from 17 healthy control subjects and 18 gestation-matched subjects with fetal growth restriction (FGR). FGR subjects were further subdivided as idiopathic ( = 9) and nonidiopathic ( = 9). Vitamin D-binding protein and 25(OH) vitamin D were measured by ELISA and normalized to protein concentration. The results showed significantly reduced levels of placental vitamin D-binding protein (control versus FGR, < 0.05, Student's -test) that were strongly associated with idiopathic fetal growth restriction ( < 0.01, Kruskal-Wallis), whereas levels of vitamin D-binding protein were not associated with placental 25(OH) vitamin D stores ( = 0.295, Pearson's correlation). As such, vitamin D-binding protein may be a factor in unexplained placental dysfunction associated with idiopathic fetal growth restriction and may potentially serve as a biomarker of this disease.
维生素D结合蛋白是一种多功能血清蛋白,具有多种与正常健康相关的作用。维生素D结合蛋白运输维生素D并影响这种关键激素的代谢,但它还具有额外的免疫调节和清除肌动蛋白的特性。我们研究了维生素D结合蛋白的表达在与胎儿生长受限相关的胎盘功能障碍中是否发生改变。从17名健康对照受试者和18名与胎儿生长受限(FGR)孕周匹配的受试者的35份胎盘中提取蛋白质。FGR受试者进一步细分为特发性(=9)和非特发性(=9)。通过酶联免疫吸附测定法测量维生素D结合蛋白和25(OH)维生素D,并将其标准化为蛋白质浓度。结果显示,胎盘维生素D结合蛋白水平显著降低(对照组与FGR组比较,<0.05,学生t检验),且与特发性胎儿生长受限密切相关(<0.01,Kruskal-Wallis检验),而维生素D结合蛋白水平与胎盘25(OH)维生素D储备无关(=0.295,Pearson相关性检验)。因此,维生素D结合蛋白可能是与特发性胎儿生长受限相关的不明原因胎盘功能障碍的一个因素,并且可能潜在地作为这种疾病的生物标志物。